CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 194 filers reported holding CLOVIS ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $6,336,000 | +114.2% | 255,289 | +55.0% | 0.00% | +100.0% |
Q4 2018 | $2,958,000 | -70.8% | 164,685 | -52.3% | 0.00% | -33.3% |
Q3 2018 | $10,136,000 | +23.6% | 345,132 | +91.3% | 0.00% | -50.0% |
Q2 2018 | $8,203,000 | -9.7% | 180,414 | +4.9% | 0.01% | 0.0% |
Q1 2018 | $9,085,000 | -57.0% | 172,062 | -44.6% | 0.01% | -57.1% |
Q4 2017 | $21,114,000 | -20.6% | 310,496 | -3.8% | 0.01% | -22.2% |
Q3 2017 | $26,584,000 | -11.1% | 322,623 | +1.0% | 0.02% | -14.3% |
Q2 2017 | $29,903,000 | +49.4% | 319,378 | +1.6% | 0.02% | +50.0% |
Q1 2017 | $20,021,000 | +65.1% | 314,453 | +15.2% | 0.01% | +55.6% |
Q4 2016 | $12,130,000 | +140.7% | 273,070 | +95.3% | 0.01% | +200.0% |
Q3 2016 | $5,040,000 | +190.5% | 139,813 | +10.5% | 0.00% | +200.0% |
Q2 2016 | $1,735,000 | -19.8% | 126,493 | +12.3% | 0.00% | -50.0% |
Q1 2016 | $2,162,000 | -43.3% | 112,620 | +3.3% | 0.00% | -33.3% |
Q4 2015 | $3,816,000 | -63.0% | 109,020 | -2.8% | 0.00% | -62.5% |
Q3 2015 | $10,319,000 | +18.0% | 112,211 | +12.7% | 0.01% | +33.3% |
Q2 2015 | $8,747,000 | +19.9% | 99,537 | +1.3% | 0.01% | +20.0% |
Q1 2015 | $7,296,000 | +19.2% | 98,291 | -10.0% | 0.01% | +25.0% |
Q4 2014 | $6,119,000 | +6.8% | 109,266 | -13.5% | 0.00% | 0.0% |
Q3 2014 | $5,729,000 | +8.0% | 126,306 | -1.4% | 0.00% | 0.0% |
Q2 2014 | $5,306,000 | -16.4% | 128,140 | +39.9% | 0.00% | -20.0% |
Q1 2014 | $6,346,000 | +13.3% | 91,618 | -1.4% | 0.01% | +25.0% |
Q4 2013 | $5,601,000 | +16.7% | 92,940 | +17.7% | 0.00% | 0.0% |
Q3 2013 | $4,798,000 | +7.0% | 78,946 | +17.9% | 0.00% | 0.0% |
Q2 2013 | $4,486,000 | – | 66,970 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |